Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Pule

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Nature Communications|February 21, 2024
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignanciesMathieu Ferrari, Matteo Righi, Vania Baldan, et al.
Nature Medicine|October 13, 2021
CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trialShaun Cordoba, Shimobi Onuoha, Simon Thomas, et al.
Science Translational Medicine|November 26, 2020
Antitumor activity without on-target off-tumor toxicity of GD2-chimeric antigen receptor T cells in patients with neuroblastomaKarin Straathof, Barry Flutter, Rebecca Wallace, et al.
Blood|August 30, 2023
CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALLSara Ghorashian, Giovanna Lucchini, Rachel Richardson, et al.
European Journal of Cancer (Oxford, England : 1990)|November 29, 2021
Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Claudia Rossig, Crystal Mackall, et al.
Research Square|September 28, 2021
Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE studyAnnika Fendler, Lewis Au, Scott T C Shepherd, et al.
Nature Cancer|February 5, 2022
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE studyAnnika Fendler, Lewis Au, Scott T C Shepherd, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Nature Communications|February 21, 2024
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignanciesMathieu Ferrari, Matteo Righi, Vania Baldan, et al.
Nature Medicine|October 13, 2021
CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trialShaun Cordoba, Shimobi Onuoha, Simon Thomas, et al.
Science Translational Medicine|November 26, 2020
Antitumor activity without on-target off-tumor toxicity of GD2-chimeric antigen receptor T cells in patients with neuroblastomaKarin Straathof, Barry Flutter, Rebecca Wallace, et al.
Blood|August 30, 2023
CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALLSara Ghorashian, Giovanna Lucchini, Rachel Richardson, et al.
European Journal of Cancer (Oxford, England : 1990)|November 29, 2021
Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Claudia Rossig, Crystal Mackall, et al.
Research Square|September 28, 2021
Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE studyAnnika Fendler, Lewis Au, Scott T C Shepherd, et al.
Nature Cancer|February 5, 2022
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE studyAnnika Fendler, Lewis Au, Scott T C Shepherd, et al.
Pageof 8